A.K. Azad
Department of Basic Medical Sciences, Faculty of Pharmacy, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, 25200 Indera Mahkota, Kuantan, Pahang, Malaysia
Mohd. Aminul Islam
Department of Computational and Theoretical Sciences, Faculty of Science, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, 25200 Indera Mahkota, Kuantan, Pahang, Malaysia
W.S. Wan Mohd Azizi
Department of Basic Medical Sciences, Faculty of Pharmacy, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, 25200 Indera Mahkota, Kuantan, Pahang, Malaysia
ABSTRACT
The study was aimed to evaluate the pharmaceutical properties of few selected generic products of ranitidine hydrochloride tablets available in retail pharmacies of Bangladesh. We collected 10 nationally manufactured generic ranitidine HCl tablets from local Market who followed USP specifications and examined their physical parameters and potency to check their compliance with the USP. The intention was to evaluate the quality of this pharmaceuticals after 20 years of implementing the National Drug Policy in 1982. All tested ranitidine tablet samples (Rt1-Rt10) were selectively collected from local retail pharmacies in Savar, Dhaka-1344, Bangladesh. Before purchasing the samples, their physical appearance, name of manufacturer, batch number, date of manufacturing, expiry date, manufacturing license number and Maximum Retail Price (MRP) were properly checked. The various parameters of the selected samples such as diameter, shape, size, weight variation, thickness, hardness, disintegration, dissolution and potency have been determined according to the American Pharmacopoeia USP 27 requirements. It was found that all ten selected products met the USP 27 specifications. The differences in hardness among the tablets were significant. Interestingly, dissolution profiles of some tablet products were not weighty different from one another, whereas those of tablets were significantly different. However, all brands complied with USP 27. It could be concluded that the selected ranitidine HCl tablets met the required USP specifications and are considered quality products in terms of the mentioned parameters.
PDF References
How to cite this article
A.K. Azad, Mohd. Aminul Islam and W.S. Wan Mohd Azizi, 2013. Appraisement of Ranitidine Hydrochloride Tablet (USP150mg) Preparations from Few Selected Companies in Bangladesh. Pakistan Journal of Nutrition, 12: 966-972.
DOI: 10.3923/pjn.2013.966.972
URL: https://scialert.net/abstract/?doi=pjn.2013.966.972
DOI: 10.3923/pjn.2013.966.972
URL: https://scialert.net/abstract/?doi=pjn.2013.966.972
REFERENCES
- Abad-Santos, F., A.J. Carcas, P. Guerra, C. Govantes, C. Montuenga, E. Gomez and J. Frias, 1996. Evaluation of sex differences in the pharmacokinetics of ranitidine in humans. J. Clin. Pharmacol., 36: 748-751.
CrossRefDirect Link - Ahmed, F., A.K. Das, U.K. Karmakar, T. Khaleque and M.C. Shill, 2003. Quality of marketed metronidazole preparations in Bangladesh-an analytical overview. J. Biological Sci., 3: 940-950.
CrossRefDirect Link - Alagusundaram, M., B. Chengaiah, S. Ramkanth, S.A. Parameswari, C. Madhu, S. Chetty and D. Dhachinamoorthi, 2009. Formulation and evaluation of mucoadhesive buccal films of ranitidine. Int. J. PharmTech. Res., 1: 557-563.
Direct Link - Anand, O.M., X.Y. Lawrence, D.P. Conner and B.M. Davit, 2011. Dissolution testing for generic drugs: An fda perspective. AAPS J., 13: 328-335.
CrossRefDirect Link - Bushra, R., M.H. Shoaib, N. Aslam, D. Hashmat and M. Rehman, 2008. Formulation development and optimization of ibuprofen tablets by direct compression method. Pak. J. Pharm. Sci., 21: 113-120.
PubMedDirect Link - Cappola, M.L., 2001. A better dissolution method for ranitidine tablets USP. Pharm. Dev. Technol., 6: 11-17.
Direct Link - Chowdhury, F.R., H.A. Ahasan and M.M. Rahman, 2006. National drug policy of Bangladesh: Some pitfalls in implementation. J. College Phys. Surg. Pak., 16: 368-368.
PubMed - Dave, B.S., A.F. Amin and M.M. Patel, 2004. Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and In vitro evaluation. AAPS PharmSciTech., 5: 77-82.
CrossRefDirect Link - Mullaicharam, A.R., J.A. Jehangir Ahmed and N. Halligudi, 2012. Evaluation of pharmaceutical equivalents of different brands of ranitidine tablets from multinational brands in oman. Int. J. Nutr. Pharmacol. Neurol. Dis., 2: 40-44.
CrossRefDirect Link - Yasmeen, R., M.H. Shoaib and H. Khalid, 2005. Comparative study of different formulations of atenolol. Pak. J. Pharm. Sci., 18: 47-51.
PubMed - Yu, L.X., J.T. Wang and A.S. Hussain, 2002. Evaluation of USP apparatus 3 for dissolution testing of immediate-release products. AAPS J., 4: 1-5.
CrossRefDirect Link